l.pires

TL2 Moderator · Aarhus

Contributes reviews on supplier material. Based in Aarhus.

Joined 19 February 2025 · last posted 3d · groups: regional-na

83 posts, newest first. Showing up to 150.

Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #95 · Practice › Dosing & titration · 25 Jul 2026 · 4 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #13 · Compounds › Tirzepatide · 21 Jul 2026 · 0 likes This follows post #10 rather than contradicting it. Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent…
Which categories are strict and which are relaxed, honestly Replied, post #24 · Start Here › Welcome · 17 Jul 2026 · 2 likes Picking up post #21: that is the part I would want checked first. The moderation log is public. Every staff action is logged with the rule cited and the reasoning…
Common supplements people ask about, assessed one at a time Replied, post #56 · Practice › Interactions · 16 Jul 2026 · 25 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
Blinding yourself: practical methods and their limits — the long version Replied, post #10 · Research Methods › N-of-1 designs · 16 Jul 2026 · 18 likes Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.
Prior authorisation: what the criteria usually require — a second dataset Replied, post #32 · Access › Insurance & coverage · 15 Jul 2026 · 3 likes post #31 answers the question as asked. The question underneath it is different. Generic versus brand: most of these compounds do not have generic versions yet. Once…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #82 · Analytics › Home & field testing · 13 Jul 2026 · 0 likes This follows post #79 rather than contradicting it. Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to…
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #15 · Practice › Interactions · 11 Jul 2026 · 8 likes post #14 answers the question as asked. The question underneath it is different. Food interactions: most interactions are absorption interactions. Some medications…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #38 · Evidence › Journal club · 8 Jul 2026 · 15 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
A structured critique template this community uses — a second dataset Replied, post #30 · Evidence › Study critique · 6 Jul 2026 · 4 likes On post #26 — agreed on the reasoning, with one qualification. Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not…
Tracking a shortage from primary sources rather than rumour Replied, post #84 · Access › Shortages · 4 Jul 2026 · 9 likes This follows post #81 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Alcohol: what is documented and what is folklore Replied, post #84 · Practice › Interactions · 30 Jun 2026 · 0 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
Insurance and replacement policies, compared Replied, post #49 · Sourcing › Logistics · 28 Jun 2026 · 5 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
Request: tag synonyms surfaced in search Replied, post #6 · Meta › Feature requests · 25 Jun 2026 · 8 likes Alternatives: if you have thought of a way the current site might already serve your need, mention it. It helps assess whether the feature is truly missing or just not…
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #11 · Analytics › Mass spectrometry · 21 Jun 2026 · 0 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #113 · Practice › Storage & stability · 9 Jun 2026 · 1 like Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
Revisiting: Mean kinetic temperature explained without the mathematics Started this topic · Practice › Storage & stability · 29 May 2026 · 0 likes Revisiting: Mean kinetic temperature explained without the mathematics Writing it up because I had to work it out twice and would rather nobody else did. Practical…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #3 · Evidence › Journal club · 26 May 2026 · 28 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #30 · Practice › Storage & stability · 16 May 2026 · 0 likes Coming back to post #28, because the follow-up matters more than the original answer. Vial integrity: once a vial is entered with a needle repeatedly, the rubber…
Follow-up: Sleep quality changes during weight loss Replied, post #17 · Wellbeing › Sleep · 6 May 2026 · 3 likes Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to months, not immediate. Improvement often is gradual rather than…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #120 · Practice › Reconstitution · 25 Apr 2026 · 0 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
Follow-up: State-level differences that actually matter Replied, post #81 · Regional › North America · 8 Apr 2026 · 24 likes On post #77 — agreed on the reasoning, with one qualification. Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer…
Follow-up: Sleep quality changes during weight loss Replied, post #2 · Wellbeing › Sleep · 7 Apr 2026 · 27 likes Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic monitoring (annually) during weight loss is prudent because severity changes.
Choosing which test to pay for, given a fixed budget Replied, post #50 · Sourcing › Independent verification · 2 Apr 2026 · 0 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
A site rotation scheme that is easy enough to actually follow Replied, post #24 · Practice › Administration · 21 Mar 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #92 · Access › Pricing · 17 Feb 2026 · 0 likes On post #88 — agreed on the reasoning, with one qualification. Price variation between pharmacies: identical prescriptions can cost different amounts at different…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #54 · Outcomes › Progress reports · 14 Feb 2026 · 0 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
MHRA statements, read directly Replied, post #88 · Regional › UK & Ireland · 13 Feb 2026 · 0 likes post #87 answers the question as asked. The question underneath it is different. Occupational health screening: some UK occupations require medical checks. Disclosure…
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #85 · Wellbeing › Mental health · 1 Feb 2026 · 29 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #66 · Clinical › Special populations · 2 Jan 2026 · 0 likes Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #78 · Practice › Interactions · 28 Dec 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #16 · Access › International · 18 Dec 2025 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #4 · marked as the solution · Analytics › COA interpretation · 5 Dec 2025 · 18 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #41 · Compounds › Semaglutide · 5 Dec 2025 · 0 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
Tracking a preprint to publication: a worked example Replied, post #50 · Evidence › Preprints · 5 Dec 2025 · 32 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #25 · Data & Tools › Calculators · 2 Dec 2025 · 0 likes On post #21 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
Second pass at: The mass-error checker and its intended scope Replied, post #70 · Data & Tools › Calculators · 22 Nov 2025 · 33 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Thyroid function tests during substantial weight change Replied, post #121 · Clinical › Bloodwork · 4 Nov 2025 · 23 likes I read post #119 twice before replying, because I had assumed the opposite. Biological variation: the person-to-person variation in a biomarker for a healthy person is…
Can a home kit substitute for a laboratory report? A careful no Replied, post #44 · Analytics › Home & field testing · 2 Nov 2025 · 20 likes Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are…
Reading a supplier's product description as a marketing document Replied, post #90 · Compounds › Other compounds · 28 Oct 2025 · 0 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
Managing an unplanned gap in supply — what changed since Replied, post #90 · Access › Shortages · 17 Oct 2025 · 0 likes Coming back to post #88, because the follow-up matters more than the original answer. Shortage predictions: regulators and suppliers issue shortage alerts before they…
Publishing an inconvenient result: a case study — the long version Replied, post #8 · Sourcing › Independent verification · 12 Oct 2025 · 10 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #144 · Data & Tools › Calculators · 8 Oct 2025 · 8 likes Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Started this topic · Compounds › Semaglutide · 26 Sep 2025 · 54 likes On the subject in the title: Semaglutide in people without diabetes: what the evidence base looks like Working notes rather than a conclusion. Session topic: STEP 2 (…
What a purity-only report leaves out Replied, post #22 · Sourcing › Independent verification · 22 Sep 2025 · 10 likes Coming back to post #20, because the follow-up matters more than the original answer. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #73 · Evidence › Journal club · 3 Sep 2025 · 25 likes I read post #71 twice before replying, because I had assumed the opposite. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #11 · Sourcing › Regulatory · 19 Aug 2025 · 3 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
What I would record differently if I started again — the long version Replied, post #7 · Outcomes › Progress reports · 15 Aug 2025 · 2 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
Asking about a compound your prescriber has not heard of Replied, post #114 · Clinical › Prescriber conversations · 3 Aug 2025 · 3 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Are there stupid questions here? A staff answer, at length Replied, post #20 · Start Here › Welcome · 28 Jul 2025 · 29 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
Coming back to: What published stability data actually covers, and what it does not Replied, post #82 · Practice › Storage & stability · 8 Jul 2025 · 2 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
Research-use-only labelling: what it means and what it does not Replied, post #9 · Sourcing › Regulatory · 6 Jul 2025 · 2 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
Repeatability versus intermediate precision Replied, post #120 · Analytics › Method validation · 2 Jul 2025 · 26 likes post #119 answers the question as asked. The question underneath it is different. Linearity: the detector response is proportional to compound concentration across the…
[2026 update] An appeal that failed, and what I would do differently Replied, post #72 · Access › Insurance & coverage · 11 Jun 2025 · 22 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #27 · Evidence › Journal club · 5 Jun 2025 · 29 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
Risk-of-bias tools and the judgement they conceal Replied, post #3 · Evidence › Meta-analyses · 21 May 2025 · 4 likes Coming back to the opening post, because the follow-up matters more than the original answer. Why forest plots are more informative than pooled numbers: they show the…
Pregnancy as an absolute contraindication Replied, post #98 · Safety › Contraindications · 20 May 2025 · 5 likes Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose adjustment and close monitoring for hypoglycemia. The combination is used with…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #51 · Sourcing › Independent verification · 5 May 2025 · 0 likes post #50 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
Follow-up: Documentation that appears only after payment Replied, post #24 · Sourcing › Red flags · 26 Apr 2025 · 4 likes Worth separating two things that post #20 runs together. Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #98 · Evidence › Journal club · 21 Apr 2025 · 0 likes This follows post #95 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #4 · Analytics › Method validation · 20 Apr 2025 · 10 likes Picking up post #3: that is the part I would want checked first. Why two laboratories may disagree: after validating the same method, they may still report different…
Follow-up: What other technical communities get right that we do not Replied, post #62 · Lounge › Off topic · 9 Apr 2025 · 1 like Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #39 · Clinical › Comorbidities · 22 Mar 2025 · 30 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #107 · Access › International · 18 Mar 2025 · 2 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
Charge states for a 4 kDa peptide, worked through Replied, post #130 · Analytics › Mass spectrometry · 17 Mar 2025 · 0 likes post #129 answers the question as asked. The question underneath it is different. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #38 · Compounds › Semaglutide · 13 Mar 2025 · 21 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
Second pass at: Pen dose counters: what a click does and does not guarantee Started this topic · Devices › Pens & autoinjectors · 12 Mar 2025 · 33 likes Second pass at: Pen dose counters: what a click does and does not guarantee — setting out what I have, and where I think it stops being reliable. A question about…
Charge states for a 4 kDa peptide, worked through Replied, post #50 · Analytics › Mass spectrometry · 8 Mar 2025 · 21 likes I read post #48 twice before replying, because I had assumed the opposite. Calibration matters: a high-resolution instrument out of calibration can report mass with ppm…
Validating a method you did not develop — does this still hold? Replied, post #42 · Analytics › Method validation · 24 Feb 2025 · 18 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #23 · Practice › Reconstitution · 30 Jan 2025 · 14 likes This follows post #20 rather than contradicting it. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at…
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #5 · Practice › Dosing & titration · 22 Jan 2025 · 0 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #93 · Compounds › Tirzepatide · 17 Dec 2024 · 1 like This follows post #90 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #32 · Compounds › Cagrilintide & amylin analogues · 7 Dec 2024 · 30 likes On post #28 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
A promotion I argued against, and why I lost Replied, post #11 · Documentation › Doc review · 22 Nov 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
EMA product information as a primary source — does this still hold? Replied, post #13 · Regional › European Union · 14 Nov 2024 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Second pass at: Gauge and length selection for subcutaneous injection Started this topic · Devices › Syringes & needles · 8 Nov 2024 · 4 likes Posting this under the heading it deserves: Second pass at: Gauge and length selection for subcutaneous injection Everything below is what sits behind that. A question…
When a red flag was a misunderstanding, and the retraction Replied, post #35 · Sourcing › Red flags · 16 Oct 2024 · 7 likes Worth separating two things that post #31 runs together. Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from…
Coming back to: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated… Replied, post #6 · Compounds › Secretagogues & GH axis · 12 Oct 2024 · 11 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
Blind submission and why it changes minds Replied, post #63 · Sourcing › Independent verification · 17 Sep 2024 · 22 likes Worth separating two things that post #59 runs together. Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services…
Circumference measurements as a poor man's composition estimate Replied, post #37 · Outcomes › Body composition · 2 Aug 2024 · 0 likes I read post #35 twice before replying, because I had assumed the opposite. Lean mass loss during rapid weight reduction: depends on protein intake, resistance training…
Guidelines revision: what changed and why Replied, post #86 · Meta › Announcements · 27 Jul 2024 · 22 likes Questions welcomed: if an announcement is unclear, asking for clarification is welcome. Staff will explain their reasoning.
How to ask for a dose change without antagonising anyone Replied, post #2 · Clinical › Prescriber conversations · 30 Jun 2024 · 0 likes This follows the opening post rather than contradicting it. Questions about dose: asking "how will we determine whether this dose is working for me" gets at the…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #9 · Practice › Dosing & titration · 5 Jun 2024 · 19 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…